Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA · NASDAQ Global Select
+$0.42 today
Vol 0.78M · Avg 0.66M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+91.89%
Period High
$59.48
Period Low
$26.33
Latest
$55.11
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cidara Therapeutics, Inc.
CDTX
$5.61B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.60B
Apellis Pharmaceuticals, Inc.
APLS
$5.25B
Amicus Therapeutics, Inc.
FOLD
$4.55B
Veracyte, Inc.
NASDAQ:VCYT
$4.23B
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.95B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.79B
Zai Lab Limited
NASDAQ:ZLAB
$2.08B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.70B
What is the latest KNSA filing?
The latest filing shown is 4 dated Jun 2, 2026.
How many recent filings does KNSA have?
Intrinsic Alpha currently shows 20 recent filings for KNSA.
Explore More
Continue the stock analysis
Jump to another research area for this company.